Risultati della ricerca - Asmussen, Jon Thor

Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis di Bjørnhart, Birgitte, Hansen, Karin Holmskov, Asmussen, Jon Thor, Jørgensen, Trine Lembrecht, Herrstedt, Jørn, Schytte, Tine

Testo Testo Testo

Multiple Myeloma Associated Bone Disease di Rasch, Stine, Lund, Thomas, Asmussen, Jon Thor, Lerberg Nielsen, Anne, Faebo Larsen, Rikke, Østerheden Andersen, Mikkel, Abildgaard, Niels

Testo Testo Testo

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer di Naghavi-Behzad, Mohammad, Oltmann, Hjalte Rasmus, Alamdari, Tural Asgharzadeh, Bülow, Jakob Lykke, Ljungstrøm, Lasse, Braad, Poul-Erik, Asmussen, Jon Thor, Vogsen, Marianne, Kodahl, Annette Raskov, Gerke, Oke, Hildebrandt, Malene Grubbe

Testo Testo Testo

FDG-PET/CT can rule out malignancy in patients with vocal cord palsy di Thomassen, Anders, Nielsen, Anne Lerberg, Lauridsen, Jeppe Kiilerich, Blomberg, Björn Alexander, Hess, Søren, Petersen, Henrik, Johansen, Allan, Asmussen, Jon Thor, Sørensen, Jesper Roed, Johansen, Jørgen, Godballe, Christian, Høilund-Carlsen, Poul Flemming

Testo Testo

Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study di Vogsen, Marianne, Jensen, Jeanette Dupont, Gerke, Oke, Jylling, Anne Marie Bak, Asmussen, Jon Thor, Christensen, Ivar Yannick, Braad, Poul-Erik, Thye-Rønn, Peter, Søe, Katrine Lydolph, Ewertz, Marianne, Hildebrandt, Malene Grubbe

Testo Testo Testo

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT di Naghavi-Behzad, Mohammad, Vogsen, Marianne, Vester, Rasmus Mølgård, Olsen, Maiken Madsen Bjerregaard, Oltmann, Hjalte, Braad, Poul-Erik, Asmussen, Jon Thor, Gerke, Oke, Vach, Werner, Kidholm, Kristian, Kodahl, Annette Raskov, Weber, Wolfgang, Hildebrandt, Malene Grubbe

Testo Testo Testo